SBIR/STTR Research Award

High Throughput Isothermal Monitoring

Award identifier 392ef7aed3a0527d3ba19d52ffe84e5459993afc52f6111b695eab156590d84eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$502,527

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Ribomed Biotechnologies, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
NRWMJLALNTY7
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The long-term goal of this work is to develop a high-throughput device for the rapid and specific detection of viral or bacterial loads from blood or tissue samples, with the use of PCR or other target amplification. The RiboMaker (tm) Pathogen Detection System, RiboPATH (tm), currently under development at Designer Genes, Inc., is a rapid, isothermal, signal amplification system for the detection of target DNA or RNA that should be the ideal signal generation chemistry for this device. It is not a target amplification technology, nor a true signal amplification technology. RiboPATH (tm) utilizes a novel and proprietary process to create thousands to millions of detectable signals for each target. These signals are generated by short oligonucleotides that are reiteratively synthesized and released by our novel RiboMaker (tm) polymerase when linked to the molecular target. In the RiboPATH (tm) Fluorescent Resonance Energy Transfer (FRET) system, the oligonucleotides produced are tagged at both the 5' and 3' ends with a set of fluorescent dyes that serve as an efficient fluorescent energy donor/acceptor pair. The dyes are enzymatically incorporated into the signal-generating oligonucleotides in a target-dependent process. Only when the two fluorescent nucleotide analogs are joined together covalently will the donor and acceptor pair come close enough together for energy transfer (FRET). Signals from these oligonucleotide products can be measured in real time without removal of the unincorporated nucleotide analog substrates. The goal of this Phase 1 proposal is to optimize the first generation of the RiboPATH (tm) detection technology.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

5 SBIR/STTR records share this UEI (2002–2019). Reported award amounts total $1,043,874. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.